Completed
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
NCT04720131
- Conditions
- Anti-PD-1 Therapy, Biliary Tract Cancer, Biliary Tract Diseases, +7 more
- Locations
-
- Beijing Friendship Hospital Beijing, Beijing Municipality, China